Multiplexed single cell transcriptomics optimizes mesodermal patterning and hemogenic endothelial output from murine embryonic stem cells
This study utilizes sci-Plex single-cell transcriptomics to optimize the generation of hemogenic endothelial cells from murine embryonic stem cells by revealing how the dose and temporal integration of Activin and BMP4 signaling pathways govern mesodermal patterning and cell fate decisions.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Inside every developing embryo, a silent, precise conversation takes place between cells, deciding which will become muscle, which will become bone, and which will become the blood that sustains life. This conversation is conducted through chemical signals, molecules that act like instructions, telling a cell where to go and what to become. In the very early stages of life, a specific group of cells known as stem cells must transform into a type of tissue called mesoderm, which eventually gives rise to the heart and the blood system. Scientists have long known that the concentration of these chemical signals matters; too much of one signal might push a cell toward becoming a heart cell, while a different amount might push it toward becoming blood. However, understanding exactly how these signals mix and change over time to create the specific blood-making cells needed for a healthy adult has been a major challenge. Creating these blood cells in a laboratory dish has proven difficult because the process is so complex, and researchers have struggled to replicate the exact conditions found inside a living embryo.
A team of researchers at the Fred Hutch Cancer Center and the University of Washington has taken a significant step forward by using a powerful new tool to watch this process unfold in real time. They worked with mouse embryonic stem cells, which are capable of turning into any cell type in the body. Instead of testing one chemical condition at a time, they used a method called sci-Plex, which allows them to expose thousands of cells to many different combinations of two key chemical signals simultaneously. These signals are known as Activin and BMP4. By applying a wide range of strengths of these two signals to the stem cells, the researchers could observe how the cells responded to every possible mix, tracking their changes at the level of individual cells. This approach allowed them to see not just the final result, but the entire journey of how a stem cell decides its fate based on the precise amount and timing of the signals it receives.
The researchers discovered that the timing and strength of these chemical signals are critical. They found that by adjusting the levels of Activin and BMP4, they could guide the stem cells to become specific types of tissue that mimic what happens in a living mouse embryo. When the cells were exposed to high levels of Activin and a moderate amount of BMP4, they were most likely to become a type of tissue called lateral plate mesoderm. This tissue is a crucial stepping stone because it contains the precursors for hemogenic endothelium, which are special blood vessel cells that have the unique ability to turn into blood cells. The study showed that this specific combination of signals, applied at the right moment in the cells' development, produced the highest number of these promising precursor cells.
Further investigation revealed that the cells generated in the dish closely resembled two different types of blood-making cells found in nature: those that appear in the yolk sac early in development and those that form inside the embryo proper, which are the precursors to the long-lasting blood stem cells found in adults. The researchers were able to distinguish between these two types by looking at specific markers on the surface of the cells. They found that the cells resembling the yolk sac type expressed a protein called LYVE1, while the cells resembling the inside-embryo type did not. This distinction is important because the inside-embryo type is the one that eventually leads to the creation of hematopoietic stem cells, the gold standard for blood regeneration. The team also tested whether adding a substance called retinoic acid could help shift the cells toward the more mature, inside-embryo type. They found that adding this substance did indeed reduce the number of yolk sac-like cells and increase the number of the inside-embryo-like cells, suggesting a way to further refine the process.
Despite these successes, the researchers were careful to note that they had not yet created fully functional, long-lasting blood stem cells that could be transplanted into a mouse and survive indefinitely. While they successfully generated the early precursors and improved the conditions to make them, the final step of turning these precursors into the robust, self-renewing stem cells found in nature remains a hurdle. The study highlights that certain genes, which are known to be essential for this final transformation in a living embryo, were missing or very low in the cells grown in the dish. This suggests that the laboratory environment is still missing some key ingredients or timing cues that are present in the natural setting.
The value of this work lies in the map it provides. By using the sci-Plex method, the researchers created a detailed guide showing exactly how different doses of chemical signals influence cell decisions. This map allows scientists to see the subtle differences between cells that look similar but have different destinies. It confirms that the path to creating blood stem cells in a dish is not a single straight line but a complex landscape where the timing and strength of signals determine the outcome. The study does not claim to have solved the problem of growing transplantable blood stem cells, but it offers a clear, data-driven roadmap for how to get closer to that goal. By understanding the precise conditions that favor the creation of the right precursor cells, future research can focus on filling in the missing pieces to eventually produce blood stem cells that are truly ready for clinical use.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.